CSTL Castle Biosciences Inc - 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 28, 2026 , Castle Biosciences, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the following matters and cast their votes as set forth below:

Proposal 1. Election of Directors

The Company’s stockholders elected the three individuals listed below as Class I Directors, each to serve until the Company’s 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The final voting results are as follows:

For

Withhold

Broker Non-Votes

Ellen Goldberg

15,455,265

7,118,166

2,415,788

Miles D. Harrison

15,607,369

6,966,062

2,415,788

Tiffany P. Olson

14,380,655

8,192,776

2,415,788

Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection of KPMG LLP by the Audit Committee of the Company’s Board of Directors as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows:

For

Against

Abstain

24,531,366

445,666

12,187

Proposal 3. Approval of the Compensation of the Company’s Named Executive Officers

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026 (the “Proxy Statement”). The final voting results are as follows:

For

Against

Abstain

Broker Non-Votes

21,280,180

1,281,394

11,857

2,415,788

Proposal 4. Approval of the Company’s Non-Employee Director Compensation Policy

The Company’s stockholders approved the Company’s non-employee director compensation policy as described in the Proxy Statement. The final voting results are as follows:

For

Against

Abstain

Broker Non-Votes

21,394,330

1,130,133

48,968

2,415,788